Genomic aging, clonal hematopoiesis, and cardiovascular disease

P Natarajan - Arteriosclerosis, thrombosis, and vascular biology, 2023 - Am Heart Assoc
Chronologic age is the dominant risk factor for coronary artery disease but the features of
aging promoting coronary artery disease are poorly understood. Advances in human …

Clinical and therapeutic implications of clonal hematopoiesis

G Petrone, I Turker, P Natarajan… - Annual Review of …, 2024 - annualreviews.org
Clonal hematopoiesis (CH) is an age-related process whereby hematopoietic stem and
progenitor cells (HSPCs) acquire mutations that lead to a proliferative advantage and clonal …

Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease

ED Gumuser, A Schuermans, SMJ Cho… - Journal of the American …, 2023 - jacc.org
Background Clonal hematopoiesis of indeterminate potential (CHIP)—the age-related clonal
expansion of blood stem cells with leukemia-associated mutations—is a novel …

Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction

M Böhme, S Desch, M Rosolowski, M Scholz… - Journal of the American …, 2022 - jacc.org
Background Clonal hematopoiesis of indeterminate potential (CHIP) is common in elderly
individuals and is associated with an increased risk of both hematologic malignancies and …

Clonal hematopoiesis of indeterminate potential from a heart failure specialist's point of view

MA Sikking, SLVM Stroeks, OJ Waring… - Journal of the …, 2023 - Am Heart Assoc
Clonal hematopoiesis of indeterminate potential (CHIP) is a common bone marrow
abnormality induced by age‐related DNA mutations, which give rise to proinflammatory …

Extending the 'host response'paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities

M Buckel, P Maclean, JC Knight, PR Lawler… - Critical Care, 2023 - Springer
Recent clinical and research efforts in cardiogenic shock (CS) have largely focussed on the
restoration of the low cardiac output state that is the conditio sine qua non of the clinical …

Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis

J Singh, N Li, E Ashrafi, LTP Thao, DJ Curtis… - Blood …, 2024 - ashpublications.org
With advances in sequencing, individuals with clonal hematopoiesis of indeterminate
potential (CHIP) are increasingly being identified, making it essential to understand its …

Distinct host-response signatures in circulatory shock: a narrative review

S Soussi, C Dos Santos, JC Jentzer, A Mebazaa… - Intensive Care Medicine …, 2023 - Springer
Circulatory shock is defined syndromically as hypotension associated with tissue
hypoperfusion and often subcategorized according to hemodynamic profile (eg, distributive …

Invasive assessment of coronary artery disease in clonal hematopoiesis of indeterminate potential

JB Heimlich, MA Raddatz, J Wells… - Circulation: Genomic …, 2024 - ahajournals.org
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) occurs due to
acquired mutations in bone marrow progenitor cells. CHIP confers a 2-fold risk of …

Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion

C Quin, EN DeJong, AJM McNaughton… - Blood …, 2024 - ashpublications.org
Somatic mutations in the TET2 gene occur more frequently with age, imparting an intrinsic
hematopoietic stem cells (HSCs) advantage and contributing to a phenomenon termed …